Intrahepatic cholangiocellular carcinoma and hepatocellular carcinoma developed after a 6-year sustained virological response to interferon therapy for chronic hepatitis C-Reference-Cited by-同舟云学术

Intrahepatic cholangiocellular carcinoma and hepatocellular carcinoma developed after a 6-year sustained virological response to interferon therapy for chronic hepatitis C

Published:2011-06 Issue:3 Volume:4 Page:167-173
ISSN:1865-7257
Container-title:Clinical Journal of Gastroenterology
language:en
Short-container-title:Clin J Gastroenterol

Author:

Takashimizu Shinji,Kojima Sei-ichiro,Nagata Junko,Nishizaki Yasuhiro,Kagawa Tatehiro,Shiraishi Koichi,Mine Tetsuya,Kaneko Jun-ichi,Kokudo Norihiro,Watanabe Norihito

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12328-011-0216-y.pdf

Reference33 articles.

1. Kasahara A, Hayashi N, Mochizuki K, Takayanagi M, Yoshioka K, Kakumu S, et al. Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group. Hepatology. 1998;27:1394–402.

2. Okanoue T, Itoh Y, Minami M, Sakamoto S, Yasui K, Sakamoto M, et al. Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in an advanced stage: a retrospective study in 1148 patients. Viral Hepatitis Therapy Study Group. J Hepatol. 1999;30:653–9.

3. Yoshida H, Arakawa Y, Sata M, Nishiguchi S, Yano M, Fujiyama S, et al. Interferon therapy prolonged life expectancy among chronic hepatitis C patients. Gastroenterology. 2002;123:483–91.

4. Marcellin P, Boyer N, Gervais A, Martinot M, Pouteau M, Castelnau C, et al. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy. Ann Intern Med. 1997;127:875–81.

5. Shiratori Y, Imazeki F, Moriyama M, Yano M, Arakawa Y, Yokosuka O, et al. Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy. Ann Intern Med. 2000;132:517–24.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Case of Intrahepatic Cholangiocarcinoma that Developed 12 Years after Sustained Virological Response was Achieved to Interferon Therapy for Chronic Hepatitis C;Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons);2022

2. A Case of Intrahepatic Cholangiocarcinoma that Developed after Treatment of Chronic Hepatitis C with Direct-acting Antiviral Agents;Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons);2022

3. A Case of Synchronous Double Cancer with Hepatocellular Carcinoma and Cholangiocellular Carcinoma Detected after Successful Interferon Therapy for Hepatitis C Virus Infection;Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association);2014